Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Library

Cyted Health

Cyted Health Website, Blog & Press Pages - aVenture Research

Library

cytedhealth.comCrawled Nov 1, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

3 pages

Conditions/conditions
Cyted’s non-endoscopic technology detects various esophageal diseases. The page describes the conditions it identifies.
Cyted Laboratory/cyted-laboratory
The page outlines the accreditations and specializations of Cyted’s laboratory services.
EndoSign/endosign
EndoSign is a non-endoscopic, capsule sponge test to protect esophageal health by detecting and monitoring for signs of pre-cancer and other diseases.

Blog

6 pages

Artificial Intelligence for early cancer detection/post/ai-for-early-cancer-detection-in-nature-medicine
Dr. Marcel Gehrung published research in *Nature Medicine* on using Cytosponge and artificial intelligence to diagnose Barrett’s esophagus.
Capsule sponge test transforms care pathways for NHS Scotland/post/capsule-sponge-test-transforms-care-pathways-in-scotland
National implementation of capsule sponge test for NHS Scotland transform care pathways, reduce pressure on endoscopy and generate cost savings.
Cyted and Microsoft Research Collaboration Published in Nature Communications/post/cyted-and-microsoft-research-collaboration-published-in-nature-communications
Cyted and Microsoft Research collaboration built novel AI models for efficient screening of cancer cells that could reduce pathologist workload by as much as 63%
Cyted’s diagnostic technology streamlines endoscopy services in secondary care/post/cyteds-diagnostic-technology-streamlines-endoscopy-services-in-secondary-care
Capsule sponge technology instrumental in transforming patient care and NHS savings

Press

6 pages

Cyted acquires Pathognomics Ltd/post/cyted-acquires-pathognomics-ltd
Acquisition supports expansion and scaling of digital pathology and diagnostic reporting services
Cyted appoints Gail Marcus as Chair of the Board/post/cyted-appoints-gail-marcus-as-chair-of-the-board
Healthcare Executive Gail Marcus appointed Chair of Cyted's Board, spearheading expansion into the US market
Cyted celebrates success amongst Project DELTA industry leaders supported by UKRI/post/cyted-celebrates-success-amongst-project-delta-industry-leaders-supported-by-ukri
Cyted collaborates on Project DELTA, which advances oesophageal cancer diagnosis.
Cyted CEO Marcel Gehrung gives evidence to House of Commons Health and Social Care Committee's Future Cancer inquiry/post/cyted-ceo-marcel-gehrung-gives-evidence-to-house-of-commons-health-and-social-care-committees-future-cancer-inquiry
Marcel Gehrung appeared in front of the Health and Social Care Committee, detailing the potential of Cyted's diagnostics technology

Careers & Hiring

1 page

Careers/careers
Cyted lists job openings on its website.

Team

1 page

Martin Frost Appointed Commercial and Strategic Advisor/post/martin-frost-commercial-and-strategic-advisor
CMR Surgical founder and CEO appointed to support rapid commercialisation of artificial intelligence and digital diagnostic products and services

About

3 pages

About Us/about-us
Equal Opportunities/equal-opportunities
Cyted Health Equal opportunities
Research/research
Cyted’s non-endoscopic technologies provide doctors with less invasive diagnostic tools for esophageal diseases. The company highlights its research and development projects.

Contact

1 page

Contact Us/contact-us

Homepage

1 page

Homepage/
Cyted develops non-endoscopic diagnostics to enable early disease detection and improve access to care.

Privacy

2 pages

Cookies Policy/cookies-policy
Cyted Health Cookies Policy
Privacy Policy/privacy-policy
Cyted Health Privacy Policy

Terms & Conditions

1 page

Modern Slavery Policy/modern-slavery-policy
Cyted Health Modern Slavery Policy